L803

L803 is a selective somatostatin receptor type 4 (SST4) agonist that can inhibit L-type calcium channel currents (ICa) . It holds potential for research into degenerative diseases of retinal ganglion cells (RGC), such as glaucoma.

C(=O)(N1[C@H](C(N[C@H](C(N[C@H](C(=O)N2[C@H](C(O)=O)CCC2)COP(=O)(O)O)=O)CCC(N)=O)=O)CCC1)[C@H]3N(C([C@@H](NC(=O)[C@H]4N(C(=O)[C@H]5N(C([C@@H](NC([C@@H](NC([C@H](CCCCN)N)=O)CCC(O)=O)=O)C)=O)CCC5)CCC4)C)=O)CCC3